A wide variety of lesions occur in maxilla. Non specificity of clinical and radiological features makes diagnosis of these lesions a difficult task. We report six interesting cases of maxillary swelling among a total number of 37 such lesions of maxilla. These six cases are as follows two cases of central giant cell granuloma, two cases of fibrous dysplasia, one case of pigmented melanotic neuroectodermal tumor and one case of solitary myofibroma.

Introduction: Neutrophil-Lymphocyte Ratio (NLR) is an easily measurable novel marker of systemic inflammation and is related to cardiovascular disease in patients with type 2 diabetes mellitus. Glycated haemoglobin A (HbA1c) levels are an indicator of blood glucose regulation. However, HbA1c usually do not predict diabetes associated complications accurately. Aim: To measure NLR and HbA1c values and to determine their association in patients with type 2 diabetes mellitus. Materials and Methods: This observational analytical study was conducted in a tertiary care centre. Data was collected over a period of six months from June 2020 to December 2020. 100 random patients diagnosed with type 2 diabetes mellitus according to American Diabetes Association (ADA) criteria were included in the study. Patients were divided into two groups, group A with HbA1c ≤7 (regulated diabetes) and group B with >7 HbA1c (unregulated diabetes). Results: Using independent t-test, the NLR ratios were found to be significantly higher in group B when compared to group A (2.41±0.11 verses 1.31±0.57, respectively). Mean HbA1c (%) levels were 6.67±0.14 and 8.79±0.21 in groups A and B, respectively. Linear regression analysis showed that NLR correlated positively with HbA1c with a p-value <0.001. Conclusion: NLR is an easily available, safe, cost-effective and a simple test. It can also guide the physician in resource limited settings like Primary Health Centres (PHC) to evaluate a patient with type 2 diabetes for microvascular and macrovascular complications. So, it can be used as a disease monitoring tool during the follow-up of diabetics.